JAN 02, 2020 8:33 PM PST

The new "tumor-on-a-chip"

In order to mimic the microenvironment of a tumor in the human body, researchers from Kyoto University have developed a device that they are describing as a 'tumor-on-a-chip'. The device is capable of mimicking the biochemical and biomechanical environments of tumors in vitro in order to allow for enhanced testing for potential new anti-cancer drugs. The research was published recently in the journal Biomaterials.

As small as a coin with a 1-millimeter well in its center, the tumor-on-a-chip is meant to mimic structurally as well as chemically a real tumor in the human body. As Science Daily describes, the small well on the chip is surrounded by 100 µm micro-posts, which support the growth of vasculature around the cultured tumor cells – a concept that is seen in human cancer tumors. To put it into simpler terms, blood vessels grow around the tiny posts to create an intertwined 3-D web on the culture.

"This 'perfusable vasculature' allows us to administer nutrients and drugs into the system to mimic the environment in the body," explains Yuji Nashimoto, first author of the study. "This allows us to have a clearer picture of the effectiveness of cancer-treating compounds."

The need for this type of technology is clear, state the researchers. Testing new drugs in cultures is time-consuming and often futile. "Potential compounds are tested using animal models and cells cultured in a dish. However, those results frequently do not transfer over to human biology," adds Nashimoto, of Tohoku University. "Furthermore, cells on a dish lack the three-dimensional structure and blood vessels, or vasculature, that keep it alive. So, we came up with a plan to construct a device that solves these issues."

Scientists develop "tumor-on-a-chip" to mimic a tumor's microenvironment. Photo: Pixabay

The findings from the researchers’ investigations show that this type of vasculature was successful in maintaining tumor cells’ healthy and proliferating so that anti-tumor drugs could be tested in more natural environs. They also found that drugs tested were most potent under flow conditions of the vasculature, proving, says lead researcher Ryuji Yokokawa, “the importance of blood flow in the vasculature when screening for drugs.”

The team of scientists hopes that their work will advance ongoing and future cancer-fighting drug trials. “Due to its size and utility, we hope the new device can expedite the tests on the countless number of potential new drugs,” concludes Yokokawa. “While many questions remain, we are happy to have developed this device and have shown that three-dimensional perfused cell culture is vital for the next step in drug discovery."

Sources: Science Daily, Biomaterials

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
DEC 21, 2019
Cancer
DEC 21, 2019
Processed meats containing nitrites linked to cancer
Since 2015, when the World Health Organization (WHO) classified processed meats as Group 1 carcinogens, science has supported the idea that these foods pos...
DEC 24, 2019
Cancer
DEC 24, 2019
The effect of aspirin on breast cancer
New research published recently in the journal Cancer aims to better understand the effects that aspirin can have on breast cancer. Previous research has s...
JAN 07, 2020
Immunology
JAN 07, 2020
"Good" T Cells Can Go "Bad," But in the Case of Cancer, That's A Good Thing
T cells may be able to reach their full potential in the fight against cancer with a little nudge. In 2010, scientists first observed CD4+ T cells transiti...
JAN 23, 2020
Cancer
JAN 23, 2020
The role of circular RNA in melanoma
New research published in the journal Cancer Cell investigates the role of circular RNAs in the spread of melanoma. Melanoma is a particularly aggressive c...
FEB 07, 2020
Genetics & Genomics
FEB 07, 2020
Mutations That Lead to Cancer May Occur Decades Before Diagnosis
As our cells age or divide, errors can accumulate in the genome they carry, which can lead to cancer, and a variety of environmental and genetic factors ca...
FEB 19, 2020
Clinical & Molecular DX
FEB 19, 2020
Forget complicated scans - ovarian cancer can be detected in the blood
Results from clinical trials performed in Melbourne, Australia have revealed the diagnostic potential of a new test for ovarian cancer. Instead of using co...
Loading Comments...